InvisionHeart picked for supply chain expo pitch competition

Locally based cardiac data venture InvisionHeart is one of five companies to have been named a finalist in Sink or Swim, a pitch competition that's part of this week's Healthcare Supply Chain Association Expo in D.C. Also in the mix are Michigan, North Carolina, Pennsylvania and Illinois. They will go before a panel of judges Tuesday. There's no money to be won, but the winner will get some advice sessions with group purchasing organization executives.

Check out more info here and catch up on our past coverage of InvisionHeart here.

Oct 5, 2015 6:53 AM

BioMimetic's Augment gets final FDA nod

The long road to the U.S. market for the Augment bone graft developed by Biomimetic Therapeutics is just about at an end. Executives at parent company Wright Medical on Tuesday said they've received final Food and Drug Administration clearance to sell Augment for ankle and hindfoot fusions. Check out the Wright team's news release here.

The Company continues to anticipate AUGMENT® revenue in the U.S. to be in the range of $10 million to $12 million in the first seven to eight months post-approval. The revenue ramp is expected to build gradually during the first six months following the launch of the product as launch activities, such as review by hospital value analysis committees and physician education, are initiated. The company expects to begin selling product in the U.S. in the next several weeks once inventory is moved into its U.S. distribution network.

Sep 2, 2015 10:56 AM

Symmetry Surgical buying clips, appliers business

North Carolina company's operations, distribution will move to Antioch HQ
Aug 28, 2015 7:11 AM

Earnings wrap: NHI, Symmetry Surgical

Medical instrument maker lifts bottom end of outlook
Aug 6, 2015 2:00 PM

Finding the sweet spot

Promising cardiac data company looks for its best place in the health care ecosystem
Jun 21, 2015 10:30 AM
 | Subscriber Only Content

InvisionHeart lands FDA clearance

Cardiac data tech company anticipates Q3 launch
May 27, 2015 7:17 AM

InvisionHeart joins CET Life Sciences Center

Cardiac technology company InvisionHeart is the newest tenant at the CET Life Sciences Center, a partnership between Cumberland Pharmaceuticals, Vanderbilt University and the state of Tennessee.

"We are very pleased to welcome InvisionHeart to the growing community of health care entrepreneurs at the CET Life Sciences Center," A.J. Kazimi, Cumberland Pharmaceuticals CEO, said in a release. "We are committed to helping build the biomedical segment of the health care industry in Middle Tennessee."

InvisionHeart raised $1.9 million last year and most recently hired Melanie Varin, formerly with GE Healthcare, to lead commercialization efforts. The company's devices allow health care providers to read and transmit real-time electrocardiogram tracings to cardiologists. The company is the sixth tenant at the CET Life Sciences Center.

"We are delighted to join the community of companies at the CET Life Sciences Center,” said Josh Nickols, President and CEO of InvisionHeart. “Our office is a great fit for the needs of a collaborative, team-oriented layout, as well as being suited to the requirements of a controlled manufacturing location. The center is conveniently located near the resources of Vanderbilt University, the Nashville Entrepreneur Center, and other healthcare companies that have supported development of the InvisionHeart ECG technology. This location and the second half of 2015 will be vitally important as we prepare for the introduction of our products to the market."

May 20, 2015 3:00 PM

Orthotics venture buys in Colorado

Frist Capital-backed team now runs 14 sites
May 15, 2015 7:46 AM

Frist Capital, BCP Holdings commit $100M to orthotic practice venture

New company will make ownership investments in O&P practices
Jan 9, 2015 3:25 PM

Locally based surgical instrument biz to list shares

Parent selling OEM unit to rival
Aug 8, 2014 12:29 PM